Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation development (Q40762790)

23 September 2017

Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation development (English)

1 reference

23 September 2017

1 reference

Jones AJ

1

1 reference

23 September 2017

Putney S

series ordinal

2

1 reference

23 September 2017

Johnson OL

series ordinal

3

1 reference

23 September 2017

Cleland JL

series ordinal

4

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 October 1997

1 reference

Advanced Drug Delivery Reviews

23 September 2017

1 reference

23 September 2017

28

1 reference

23 September 2017

1

1 reference

23 September 2017

71-84

1 reference

Growth hormone secretion in normal prepubertal children: importance of relations between endogenous secretion, pulsatility and body mass

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Defining growth hormone deficiency in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Preparation and properties of growth hormone from human and monkey pituitary glands.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Failure of hypophyseal growth hormone to produce nitrogen storage in a girl with hypophyseal dwarfism.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Human growth hormone replacement therapy: pharmacological and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Effect of growth hormone on short normal children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Metabolic effects of GH: a rationale for continued GH treatment of GH-deficient adults after cessation of linear growth.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Decreased plasma and extracellular volume in growth hormone deficient adults and the acute and prolonged effects of GH administration: a controlled experimental study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

The use of recombinant human growth hormone in short children with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Growth hormone therapy in Turner syndrome. Analysis of long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Properties of spontaneous growth hormone secretory bursts and half-life of endogenous growth hormone in boys with idiopathic short stature. Genentech Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Variability in the quantitation of circulating growth hormone using commercial immunoassays

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Subcutaneous growth hormone administration in growth-hormone-deficient children. Continuous plus pulsatile overnight versus single daily injection: effects on growth rate velocity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Stability and characterization of human growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Separation of oxidized human growth hormone variants by reversed-phase high-performance liquid chromatography. Effect of mobile phase pH and organic modifier

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Conformational changes in the reversed phase liquid chromatography of recombinant human growth hormone as a function of organic solvent: the molten globule state

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

A month-long effect from a single injection of microencapsulated human growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Stabilization of protein structure by sugars

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Dimerization of human growth hormone by zinc

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Zinc in the anterior pituitary of rat: a histochemical and analytical work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Role of aggregated human growth hormone (hGH) in development of antibodies to hGH

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

The stabilization and encapsulation of human growth hormone into biodegradable microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

Factors affecting the in vitro release of recombinant human interferon-gamma (rhIFN-gamma) from PLGA microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900051-3

7 January 2021

10.1016/S0169-409X(97)00051-3

Identifiers

DOI

1 reference

23 September 2017

1 reference